Monday, October 18, 2021 2:40:51 AM
I'll Alert you of stocks to Buy,
before the Run happens !
NSAV Security Details
Share Structure
Market Value1..............$233,529,888 a/o Oct 15, 2021
Authorized Shares......6,000,000,000 a/o Oct 18, 2021
Outstanding Shares....5,912,149,072 a/o Oct 18, 2021
Restricted.......................505,164,147 a/o Oct 18, 2021
Unrestricted................5,406,984,925 a/o Oct 18, 2021
Held at DTC................Not Available
Float..................................4,772,373,568 Mar 31, 2021
Par Value 0.001
Authorized Shares,
has No Bearing on the price.
The Shares Authorized,
is not used in any fundamental of financial calculation,
to determine company value.
_________________________________________________________________
https://www.ldmicro.com/profile/NSAV
http://www.allotcbb.com/quote.php?symbol=NSAV
https://www.otcmarkets.com/stock/NSAV/security
https://www.otcmarkets.com/stock/NSAV/news
https://www.otcmarkets.com/stock/NSAV/disclosure
https://www.quotemedia.com/portal/history?qm_symbol=NSAV
07/02/2021
NSAV
Announces Plan
to Launch Regulated
CRYPTOCURRENCY EXCHANGE
https://www.otcmarkets.com/stock/NSAV/news/NSAV-ANNOUNCES-PLAN-TO-LAUNCH-REGULATED-CRYPTOCURRENCY-EXCHANGE?id=310002
_________________________________________________________________
_________________________________________________________________
Sell after an Elliott Wave 5-Wave Advance
_________________________________________________________________
Buy after an Elliott Wave 5-Wave Decline
_________________________________________________________________
_________________________________________________________________
_________________________________________________________________
_________________________________________________________________
_________________________________________________________________
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM